Cancer vaccines are goal of new Oxford University company
OxVax, a spinout from Oxford University, has formed with the objective of producing vaccines for cancer.
We publish news of technology innovations, investment opportunities, together with updates from spin-out & start-up companies and licensees
OxVax, a spinout from Oxford University, has formed with the objective of producing vaccines for cancer.
The Oxford spinout will draw on a multi-discipline approach for therapies which work with a patient to eliminate cancer
Counterfeit medicine, which can prove both costly and deadly, target of new collaboration with Oxford University.
Your quarterly review of activity from Oxford University Innovation.
The breakthrough diagnostics platform will offer clinicians a new path to evaluating the potential advancement of Alzheimer's Disease.
Oxford spinout Spybiotech partners Serum Institute of India on new potential vaccine for COVID-19.
Careershe aims to provide smartphone-based career advice to Chinese students
OUI's momentum continues to build even under lockdown in a COVID-defying quarter.
New Oxford spinout Oxsed will lead commercialisation of rapid, cost-effective COVID-19 test.